In looking into why my prescription drug is out of stock everywhere, I learned some lots of a generic version manufactured by Zhejiang Huahai Pharmaceutical were recalled because they were contaminated with N-methylnitrosobutyric acid, a potential carcinogen. Fortunately the ones I had been getting were not in the recall.
So the supply chain was already partially disrupted due to the recall, and there weren't enough in the pipeline to handle another disruption of supply.
This kind of thing does not bode well for the pharmaceuticals made in China...and will probably cause prescription drug prices to go up across the board.
https://www.webmd.com/heart/news/20180928/fda-bans-import-of-meds-from-chinese-firm
So the supply chain was already partially disrupted due to the recall, and there weren't enough in the pipeline to handle another disruption of supply.
This kind of thing does not bode well for the pharmaceuticals made in China...and will probably cause prescription drug prices to go up across the board.
https://www.webmd.com/heart/news/20180928/fda-bans-import-of-meds-from-chinese-firm
Sept. 28, 2018 -- The FDA on Friday moved to block all imports of drugs made with ingredients made by a Chinese plant at the center of a massive recall of heart and blood pressure medications.
The agency says Zhejiang Huahai Pharmaceuticals will be on what’s called “import alert” until it “fully determines how impurities were introduced into its API,” or active pharmaceutical ingredient, and fixes its quality systems.
“The import alert stops all API made by ZHP and finished drug products made using ZHP’s API from legally entering the United States.”
The move comes after the FDA recalled blood pressure and heart failure medicines because of the discovery of at least two potentially cancer-causing impurities.